NHẬN XÉT TÌNH TRẠNG THIẾU MÁU Ở NGƯỜI SUY THẬN MẠN LỌC MÁU CHU KỲ TẠI BỆNH VIỆN ĐA KHOA MỸ ĐỨC

Abstract

Objectives: To evaluate the anemia status of patients with chronic kidney disease undergoing maintenance hemodialysis at My Duc General Hospital and to determine the association between anemia severity and selected clinical and laboratory factors. Subjects and methods: A cross-sectional descriptive study was conducted on 148 end-stage chronic kidney disease patients receiving maintenance hemodialysis from April to August 2025 at My Duc General Hospital. Results: The mean age of the study population was 56.9 ± 14 years, with patients aged >60 years accounting for the largest proportion (46.6%). The mean hemoglobin level was 107.6 ± 16.5 g/L. The prevalence of anemia was 72.2%, of which mild anemia accounted for 58.8%, moderate anemia 12.8%, and severe anemia 0.6%. The remaining 27.8% of patients had no anemia. Normocytic anemia was observed in 81.3% of cases. All patients (100%) were prescribed subcutaneous erythropoiesis-stimulating agents, and 90% received intravenous iro supplementation. The mean monthly EPO dose was 28,000 ± 13,000 IU. Hemoglobin concentration showed apositive correlation with serum ferritin (r = 0.14, p < 0.05). Serum ferritin levels demonstrated a strong positive correlation with the duration of hemodialysis (p < 0.05). The mean ferritin levels differed significantly across anemia severity categories (p < 0.05).